M. N. V. Ravi Kumar

Has grant

Distinguished University Research Professor

The University of Alabama

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. M. N. V. Ravi Kumar is a Distinguished University Research Professor at The University of Alabama, USA. His research focuses on nanotechnology applications in drug delivery, anti-inflammatory therapies, and the interplay between polyphenols and pharmaceutical drugs, particularly concerning type 2 diabetes and opioid addiction. Recent publications highlight innovative approaches in using nanoparticles for enhanced therapeutic outcomes and the mitigation of drug-induced toxicity.

Recent Grants

Grant: Close

Training the next generation graduate student in lupus research

Open Date: 2023-01-25

Close Date: 2025-01-24

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

View details

Meenakshi Arora

The University of Alabama

UNITED STATES

View details

Ingrid Heyns

University of Alabama, Tuscaloosa

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

M. N. V. Ravi Kumar

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (15)

Urolithin A-laden functional nanoparticles alleviate cisplatin-induced cardiotoxicity in mice by inhibiting inflammation-induced lymphangiogenesis

Dual-Function Polyester Nanoparticles for Amplified Anti-Inflammatory Effects

UPLC-MS/MS Method for Simultaneous Quantification of Cyclosporine A and Urolithin A in Plasma and Interspecies Analysis Across Mammals Including Humans

Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: Challenges, risks, and strategies

Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction

Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein

Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes

Chronic Interstitial Nephritis in Agricultural Communities: Observational and Mechanistic Evidence Supporting the Role of Nephrotoxic Agrochemicals

Systemic Anti-Inflammatory Therapy Aided by Curcumin-Laden Double-Headed Nanoparticles Combined with Injectable Long-Acting Insulin in a Rodent Model of Diabetes Eye Disease

Rationally Designed Naringenin-Conjugated Polyester Nanoparticles Enable Folate Receptor-Mediated Peroral Delivery of Insulin

Nano-encapsulation strategies to circumvent drug-induced kidney injury and targeted nanomedicines to treat kidney diseases

Paclitaxel and Urolithin A Prevent Histamine-Induced Neurovascular Breakdown Alike, in an Ex Vivo Rat Eye Model

Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation

Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in Mice

A highly potent lymphatic system–targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus

Collaborators (7)

Yabo Niu

Raghu Ganugula

Michael Holliday

Erin Scott

Dhaval K. Shah

Meenakshi Arora

Ingrid Heyns

Make your next move.